Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1.5 Entries for Biological Products<br />
Specified biological products<br />
1) Regulatory classification<br />
Specified biological products<br />
2) Name<br />
For genetic recomb<strong>in</strong>ants, “recomb<strong>in</strong>ant”<br />
is <strong>in</strong>cluded immediately after the<br />
non-proprietary name<br />
3) Beg<strong>in</strong>n<strong>in</strong>g of the package <strong>in</strong>sert (before<br />
the “Warn<strong>in</strong>g”)<br />
(1) Risk of spread of <strong>in</strong>fections derived<br />
from raw materials can not be<br />
completely elim<strong>in</strong>ated.<br />
(2) Summary of safety measures<br />
undertaken to prevent spread of<br />
<strong>in</strong>fection.<br />
(3) Use must be kept to a m<strong>in</strong>imum after<br />
careful <strong>in</strong>vestigation of necessity <strong>in</strong><br />
treatment of disease.<br />
4) Composition <strong>and</strong> description<br />
(1) Names of <strong>in</strong>gredients among raw<br />
materials <strong>and</strong> packag<strong>in</strong>g materials<br />
derived from humans or other<br />
organisms<br />
(2) Names of parts of humans or other<br />
organisms among raw materials<br />
(3) Name of country where blood was<br />
collected as a raw material <strong>and</strong><br />
collection methods (donor blood or<br />
non-donor blood)<br />
5) Precautions, Important Precautions<br />
Health professionals such as physicians<br />
must expla<strong>in</strong> to persons us<strong>in</strong>g the drug<br />
<strong>Pharmaceutical</strong> <strong>Regulations</strong> <strong>in</strong> <strong>Japan</strong>:<br />
the efficacy <strong>and</strong> safety <strong>and</strong> other<br />
measures required for proper use of the<br />
drug concerned.<br />
6) Precautions concern<strong>in</strong>g use<br />
Health professionals such as physicians<br />
must record the names <strong>and</strong> addresses of<br />
persons us<strong>in</strong>g the drug <strong>and</strong> preserve<br />
such records <strong>in</strong> medical <strong>in</strong>stitutions, etc.<br />
7) Other items required for proper use<br />
Biological products (exclud<strong>in</strong>g specified<br />
biological products<br />
1) Regulatory classification:<br />
Biological product<br />
2) Name:<br />
For genetic recomb<strong>in</strong>ants, (recomb<strong>in</strong>ant)<br />
is <strong>in</strong>cluded immediately after the<br />
non-proprietary name<br />
3) Composition <strong>and</strong> description:<br />
(1) Names of <strong>in</strong>gredients among raw<br />
materials <strong>and</strong> packag<strong>in</strong>g materials<br />
derived from humans or other<br />
organisms<br />
(2) Names of parts of humans or other<br />
organisms among raw materials<br />
(3) Name of country where blood was<br />
collected as a raw material <strong>and</strong><br />
collection methods (donor blood or<br />
non-donor blood)<br />
4) Other items required for proper use<br />
1.6 Br<strong>and</strong> Names of Prescriptions Drugs<br />
Pr<strong>in</strong>ciples for nam<strong>in</strong>g of br<strong>and</strong>s of<br />
2011-3 - 172 -